Sanofi

Pursue Progress. Discover Extraordinary.

Science has been our calling from the beginning. Sanofi’s heritage of turning the impossible into the possible stretches back to the 19th century — a rich history of healthcare innovation built by diverse companies united by one shared purpose. More than 150 years later, that spirit lives in everything we do and every person we serve — from the patients who take our medicines, to the healthcare professionals who trust us, to the 83,000+ employees and communities around the world who make it all possible. And today, we’re writing the next chapter of that legacy.

We are an R&D-driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth.

Better is out there. Better medications, better outcomes, better science. And it all starts with people like you — from different backgrounds, in different locations, doing different roles — united by a single mission: we chase the miracles of science to improve people’s lives.

Take the most important step in your career and help us change the lives of patients, families, and communities for the better.

Explore Open Roles →

  • Featured Employer
What could we achieve together? Sign up today and discover our latest opportunities as soon as they’re available.
Reinvention is in our DNA. It’s what drove our evolution from a small French enterprise to one of the world’s leading biopharma companies — present in 70+ countries and growing. Whether it’s harnessing AI to shorten drug-discovery timelines, pioneering transformative treatments, or building trust in healthcare systems worldwide, you could be helping our teams make life better for patients, partners, and communities.

This is where you grow your career. We open the door for you to explore new roles, take on stretch assignments, and connect with people driven by a shared purpose. Our culture of high performance and belonging is grounded in four core values:: Aim Higher, Act for Patients, Be Bold, and Lead Together.

At Sanofi, we believe every person can lead from where they are. You’ll learn to grow your skills and evolve as a leader through our Leadership Frame. Connect with mentors via our Career Hub, and explore new possibilities through “gigs”, where you’ll work on short-term projects to try something new on another team. You’ll do it all with our full support, increasing your exposure to business leaders, and expanding your network across the industry.
All Well, together. We support healthy bodies, healthy minds, healthy financials, and a healthy working culture for all Sanofians. Our dedication to improving people’s lives starts at home, with the health and wellbeing of our employees and their families.
We want you to share your voice and challenge us, even when it might feel uncomfortable. We’ll help turn your ideas into action, based on tangible measures. Because it’s action, not intent, that makes change sustainable and gives us our Diversity Edge.

We’re the first in pharma to have a Diversity, Equity and Inclusion (DE&I) Board with external members. And every member of our Executive Committee is represented either on the DE&I board or as a sponsor of a global Employee Resource Group (ERG). Diversity is our strength. Boldly, proudly and unapologetically. We’re All In on DE&I. Come and be part of it.
What is the Sanofi Feeling?

You are unique. How you feel on any given day is unique. Who you are with, and the environment you’re in, has the power to shape and enhance how you feel. At Sanofi, it’s not just about the chair you sit in. We’ve blended art with science and looked at every detail to match your uniqueness.

We’re transforming healthcare and improving lives through our work, our people, and our stories. You’ll get a glimpse of what life here is like, you’ll hear inspiring stories and you’ll dive into the projects that reveal the miracles of science. Let’s live extraordinarily.
AWARDS
  • Sanofi Human Rights Campaign award.png
  • Sanofi award_usa-2.png
  • Sanofi award_usa-3.png
  • 2023 Best Places to Work
  • 2022 Best Places to Work
NEWS
Two weeks after reporting a 45 percent growth in revenue for the third quarter, compared to last year, Swedish Orphan Biovitrum AB (Sobi) has snapped up the U.S. rights to AstraZeneca’s respiratory drug, Synagis, a drug used to treat RSV in infants, for $1.5 billion.
Researchers at the University of California, San Diego (UCSD) ran successful animal studies of a gene therapy that appeared to cure a disease in mice similar to amyotrophic lateral sclerosis (ALS), sometimes also known as Lou Gehrig’s Disease.
Nearly two weeks after the U.S. Food and Drug Administration approved Sanofi and Regeneron’s Dupixent as an add-on maintenance therapy for moderate to severe asthma, the France-based company reported a surge in sales for the medication in its most recent quarterly report.
To suggest that the pharma industry is a reluctant partner in President Donald Trump’s attempts to decrease drug prices is to overstate the fact. But now the industry appears to be pushing back, at least a little bit.
However, because the trial did show some efficacy and met other secondary endpoints, the companies are continuing to analyze the data and decide on their next moves.
FDA
The FDA approved Sanofi and Regeneron’s Dupixent (dupilumab) as an add-on maintenance therapy for patients with moderate-to-severe asthma. The approved group is age 12 years and older with either an eosinophilic phenotype or with an oral corticosteroid-dependent asthma.
FDA
This week will have moderate activity by the U.S. Food and Drug Administration (FDA). Although they jumped the gun on Regeneron and Sanofi’s cancer drug, there are still plenty of other decisions being made this week. Here’s a look.
The company, with sites in Seattle and South San Francisco, focuses on next-generation oncology therapeutics. It recently completed a portfolio review and decided to focus its energies and existing capital on G100 and abandoned its CMB305 program.
The Minnesota Attorney General is calling out Sanofi-Aventis, Novo Nordisk and Eli Lilly over alleged price gouging for insulin. This week Minnesota Attorney General Lori Swanson filed a lawsuit against the three companies over insulin price hikes.
JOBS
IN THE PRESS